Global Health Press

Tag - mRNA vaccines

GHP NewsLatest Science

ViVa News — Week 28

Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...

15 July, 2026
2 min read
GHP NewsLatest Science

Literature update ViVa week 24-2026

=1. Mpox joins the mRNA club: BioNTech’s first in-human BNT166a data hint at broad orthopox potential—but neutralizing titers fade fast In this phase 1, first-in-human, open-label dose escalation study, healthy Vaccinia...

18 June, 2026
11 min read
GHP NewsInfographic

Vaccine additives and residuals

Download Infographic Overview Vaccines contain active ingredients (antigens; mRNA) and inactive ingredients such as stabilizers, antimicrobials, inactivating agents, antibiotics, and residues from the production...

14 January, 2026
1 min read
GHP News

EMA aims to develop guideline for mRNA vaccines

The European Medicines Agency (EMA) has created a concept paper that addresses the need to establish a guideline on the quality aspects of messenger RNA (mRNA) vaccines, emphasizing the number of clinical trial...

13 July, 2023
1 min read